NDC Code(s) : 51956-0001-1, 51956-0001-7, 51956-0002-1, 51956-0002-7, 51956-0003-1, 51956-0003-7
Packager : Zydus Lifesciences Limited
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
RivastigmineRivastigmine PATCH, EXTENDED RELEASE | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
RivastigmineRivastigmine PATCH, EXTENDED RELEASE | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
RivastigmineRivastigmine PATCH, EXTENDED RELEASE | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
LABELER - Zydus Lifesciences Limited(650461283) |
REGISTRANT - Zydus Lifesciences Limited(650461283) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Zydus Lifesciences Limited | 650461283 | ANALYSIS(51956-0001, 51956-0002, 51956-0003), MANUFACTURE(51956-0001, 51956-0002, 51956-0003) |
PRINCIPAL DISPLAY PANEL
Rx only
NDC 51956-0001-7
Rivastigmine
Transdermal System
Each System Delivers 4.6 mg/24 hours
For Transdermal Use Only.
Contains 30 systems
zydus Pharmaceuticals USA
Rx only
NDC 51956-0002-7
Rivastigmine
Transdermal System
Each System Delivers 9.5 mg/24 hours
For Transdermal Use Only.
Contains 30 Systems
zydus Pharmaceuticals USA
Rx only
NDC 51956-0003-7
Rivastigmine
Transdermal System
Each System Delivers 13.3 mg/24 hours
For Transdermal Use Only.
Contains 30 Systems
zydus Pharmaceuticals USA